Jun 01, 2020
BIOTRONIK Awarded Group Purchasing Contract for Coronary Products from Vizient
Feb 24, 2020
BIOTRONIK's Ultrathin Strut Orsiro Coronary Drug-Eluting Stent Continues to Deliver Excellent Results After Three Years
Jan 27, 2020
BIOTRONIK, Inc. Appoints David Hayes, MD, as Chief Medical Officer
Sep 16, 2019
Proximo Medical Named the Commercialization Partner for BIOTRONIK, Inc.'s Peripheral Vascular Intervention Portfolio in Select U.S. Markets
Jul 31, 2019
Prix Galien Selects BIOTRONIK's PK Papyrus Covered Coronary Stent as Award Finalist
Jul 08, 2019
BIOTRONIK Receives FDA Clearance on Next-Gen Injectable Cardiac Monitor: BIOMONITOR III
May 06, 2019
Focusing on Women: BIOTRONIK Launches Study to Understand the Impact of ICDs in NICM Patients
Apr 29, 2019
US Physicians Now Treating Patients with BIOTRONIK's Ultraslim Acticor DX Devices
Feb 22, 2019
FDA Approves BIOTRONIK's Ultrathin Orsiro Stent for the Treatment of Coronary Artery Disease
Sep 14, 2018
Every Second Counts: BIOTRONIK's PK Papyrus Stent for Coronary Perforations Approved for Use in the US
Aug 27, 2018
BIOTRONIK Advances Arrhythmia Detection and Diagnosis with MoMe Cardiac Monitor in the US
Apr 03, 2018
Improving Cardiology Care: BIOTRONIK US to Distribute Aziyo ECM Envelopes
Mar 07, 2018
Innovation that Matters: SXSW Selects BIOTRONIK MRI AutoDetect as Innovation Awards Finalist
Aug 28, 2017
ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
Aug 22, 2017
Getinge announces full U.S. availability of Pulsar®-18 self-expanding stent from BIOTRONIK for patients with peripheral artery disease
Aug 21, 2017
BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
Jun 07, 2017
BIOTRONIK Launches Edora Pacemaker Series with MRI AutoDetect Technology